Generation Bio Co. (GBIO)

Generation Bio Co. Statistics

Total Valuation

GBIO has a market cap or net worth of $40.76 million. The enterprise value is -$65.28 million.

Market Cap	40.76M
Enterprise Value	-65.28M

Important Dates

The next estimated earnings date is Wednesday, March 5, 2025, after market close.

Earnings Date	Mar 5, 2025
Ex-Dividend Date	n/a

Share Statistics

GBIO has 66.79 million shares outstanding. The number of shares has increased by 5.77% in one year.

Current Share Class	66.79M
Shares Outstanding	66.79M
Shares Change (YoY)	+5.77%
Shares Change (QoQ)	+0.31%
Owned by Insiders (%)	6.12%
Owned by Institutions (%)	66.25%
Float	48.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.18
Forward PS	5.99
PB Ratio	0.39
P/TBV Ratio	0.39
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.34, with a Debt / Equity ratio of 0.90.

Current Ratio	6.34
Quick Ratio	6.20
Debt / Equity	0.90
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -86.50% and return on invested capital (ROIC) is -23.85%.

Return on Equity (ROE)	-86.50%
Return on Assets (ROA)	-19.29%
Return on Invested Capital (ROIC)	-23.85%
Return on Capital Employed (ROCE)	-44.49%
Revenue Per Employee	$106,793
Profits Per Employee	-$836,046
Employee Count	174
Asset Turnover	0.06
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -69.03% in the last 52 weeks. The beta is 2.69, so GBIO's price volatility has been higher than the market average.

Beta (5Y)	2.69
52-Week Price Change	-69.03%
50-Day Moving Average	0.94
200-Day Moving Average	2.16
Relative Strength Index (RSI)	28.70
Average Volume (20 Days)	453,652

Short Selling Information

The latest short interest is 2.30 million, so 3.45% of the outstanding shares have been sold short.

Short Interest	2.30M
Short Previous Month	2.16M
Short % of Shares Out	3.45%
Short % of Float	4.74%
Short Ratio (days to cover)	3.49

Income Statement

In the last 12 months, GBIO had revenue of $18.58 million and -$145.47 million in losses. Loss per share was -$2.19.

Revenue	18.58M
Gross Profit	-41.44M
Operating Income	-97.27M
Pretax Income	-158.43M
Net Income	-145.47M
EBITDA	-92.19M
EBIT	-97.27M
Loss Per Share	-$2.19

Balance Sheet

The company has $184.77 million in cash and $93.78 million in debt, giving a net cash position of $106.03 million or $1.59 per share.

Cash & Cash Equivalents	184.77M
Total Debt	93.78M
Net Cash	106.03M
Net Cash Per Share	$1.59
Equity (Book Value)	104.44M
Book Value Per Share	1.56
Working Capital	161.09M

Cash Flow

In the last 12 months, operating cash flow was -$97.76 million and capital expenditures -$6.60 million, giving a free cash flow of -$104.36 million.

Operating Cash Flow	-97.76M
Capital Expenditures	-6.60M
Free Cash Flow	-104.36M
FCF Per Share	-$1.56

Margins

Gross Margin	-222.99%
Operating Margin	-523.47%
Pretax Margin	-782.87%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.77%
Shareholder Yield	-5.77%
Earnings Yield	-356.93%
FCF Yield	-256.05%

Analyst Forecast

The average price target for GBIO is $6.50, which is 965.23% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.50
Price Target Difference	965.23%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	26.03%
EPS Growth Forecast (5Y)	-15.72%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

GBIO has an Altman Z-Score of -3.58 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.58
Piotroski F-Score	3